Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GPCR biased ligands
Research
How nematode worms could inspire safer opioid use
A Scripps Research team identified the GPR139 receptor as a regulator that could reduce opioids' toxic withdrawal effects.
Angus Liu
Aug 15, 2019 2:00pm
BI broadens pact with Vanderbilt to develop drugs for brain disorders
Jan 7, 2019 12:28pm
Escient Pharma grabs $40M to push orphan GPCR drugs into the clinic
May 9, 2018 8:00am
Astellas to buy GPCR specialist Ogeda for €500M upfront
Apr 3, 2017 4:24am
